Theraclion SA (TCLIF)
OTCMKTS · Delayed Price · Currency is USD
0.3200
+0.3198 (159,900.00%)
At close: Aug 26, 2024
Theraclion Market Cap
Theraclion has a market cap or net worth of $33.4 million as of January 8, 2026. Its market cap has increased by 98.80% in one year.
Market Cap
33.40M
Enterprise Value
37.38M
Revenue
2.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.32
Market Cap Chart
Since April 25, 2014, Theraclion's market cap has decreased from 51.93M to 33.40M, a decrease of -35.68%. That is a compound annual growth rate of -3.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 33.38M | 0.52% |
| Dec 31, 2025 | 33.21M | 110.53% |
| Dec 31, 2024 | 15.77M | -16.95% |
| Dec 29, 2023 | 18.99M | -32.03% |
| Dec 30, 2022 | 27.94M | -17.58% |
| Dec 31, 2021 | 33.90M | -10.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 781.81M |
| Glass House Brands | 714.29M |
| Elite Pharmaceuticals | 516.25M |
| Northwest Biotherapeutics | 499.37M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 280.10M |